Ceribell to Report Third Quarter 2026 Financial Results on November 3, 2026GlobeNewsWire · 4 days ago
Ceribell Receives FDA 510(k) Clearance for Quantitative EEG Trending and Amplitude-Integrated EEG AnalysisGlobeNewsWire · Sep 30, 2026
BlackRock Inc. Acquires New Holdings in CeriBell, Inc. $CBLLDefense World · Sep 2, 2026
Bank of America Corp DE Has $5.86 Million Position in CeriBell, Inc. $CBLLDefense World · Aug 27, 2026
CeriBell Expands EEG Platform Beyond Seizures With Delirium, Pediatric PushMarketBeat · Aug 12, 2026
CeriBell, Inc. (CBLL) Q2 2026 Earnings Call TranscriptSeeking Alpha · Aug 11, 2026CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 10, 2026 | -$0.47 | -$0.51 | Miss |
| May 11, 2026 | -$0.39 | -$0.52 | Miss |
| Feb 24, 2026 | -$0.43 | -$0.36 | Beat |
| Nov 4, 2025 | -$0.43 | -$0.37 | Beat |
| Aug 5, 2025 | -$0.40 | -$0.38 | Beat |
| May 8, 2025 | -$0.43 | -$0.36 | Beat |